---
category: market-operations
circular_id: f5f39bf4cbe91e17
date: '2025-11-13'
description: Settlement calendar for the takeover acquisition window of J.B. Chemicals
  & Pharmaceuticals Limited to be conducted from November 18, 2025 to December 1,
  2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={1AD7FE98-3691-4DA5-A44D-EA004EF322DE}&noticeno=20251113-42&dt=11/13/2025&icount=42&totcount=68&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Specific settlement schedule for takeover acquisition affecting shareholders
  and trading members of J.B. Chemicals & Pharmaceuticals Limited during the specified
  bidding window
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251113-42&attachedId=
processing:
  attempts: 1
  content_hash: ee40c53a252ae8ff
  processed_at: '2025-11-13T15:38:15.017014'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-13T12:35:09+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={1AD7FE98-3691-4DA5-A44D-EA004EF322DE}&noticeno=20251113-42&dt=11/13/2025&icount=42&totcount=68&flag=0
severity: medium
source: bse
stocks:
- JBCHEPHARM
tags:
- demat-shares
- early-pay-in
- otb
- settlement
- takeover
title: Settlement Schedule Offer to Buy – Acquisition Window (Takeover) for J.B. CHEMICALS
  & PHARMACEUTICALS LIMITED
---

## Summary

BSE has announced the settlement calendar for the Offer to Buy – Acquisition Window (Takeover) of J.B. CHEMICALS & PHARMACEUTICALS LIMITED. The takeover window will run from November 18, 2025 to December 1, 2025, with settlement number 2025121. Obligation download is scheduled for December 12, 2025, and final settlement date is December 15, 2025.

## Key Points

- Settlement Type: Takeover
- Settlement Number: 2025121
- Bid Start Date: November 18, 2025
- Bid End Date: December 1, 2025
- Obligation Download: December 12, 2025
- Settlement Date: December 15, 2025
- Demat shares must be delivered through Early Pay-in of Shares mechanism only
- Market Type designation: "(Takeover)" must be used in depository systems
- Members must refer to Notice No.20200528-32 dated May 28, 2020 for revised acquisition guidelines

## Regulatory Changes

No new regulatory changes introduced. This circular implements existing framework for acquisition of shares through stock exchange as per revised guidelines referenced in Notice No.20200528-32 dated May 28, 2020.

## Compliance Requirements

- **Members/Custodians**: Must deliver demat shares only through Early Pay-in of Shares mechanism available in both depositories (CDSL and NSDL)
- **Market Type Usage**: Must use Market Type "(Takeover)" and settlement number 2025121 in depository systems
- **Early Pay-in Timing**: Participants must ensure early pay-in effects are reflected in BSE/ICCL systems before prescribed timelines for accepting/confirming bids
- **Securities Earmarking**: CDSL & NSDL early pay-in securities will be earmarked/blocked in client accounts with requisite market type and settlement number
- **EPN File**: Members and Custodians are NOT required to upload any EPN file
- **Stamp Duty**: Members must refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges

## Important Dates

| Event | Date |
|-------|------|
| Bid Start Date | November 18, 2025 |
| Bid End Date | December 1, 2025 |
| Obligation Download | December 12, 2025 |
| Settlement Date | December 15, 2025 |

## Impact Assessment

**Market Impact**: Medium - Affects shareholders of J.B. Chemicals & Pharmaceuticals Limited who wish to participate in the takeover offer during the specified bidding window.

**Operational Impact**: Medium - Trading members and custodians must ensure compliance with early pay-in requirements and proper use of settlement number and market type designations. Early coordination required to complete depository processes before bid confirmation deadlines.

**Stakeholder Impact**: Shareholders have a 14-day window (November 18 to December 1, 2025) to participate in the acquisition offer. Members and custodians must manage client securities earmarking and blocking processes in coordination with both depositories.

**Contact Information**: For clarifications, members and custodians can contact ICCL Help Desk at 022-69158590/45720490/45720690 or email iccl.helpdesk@icclindia.com